THE EFFECT OF PRIOR DOCETAXEL TREATMENT IN PATIENTS WITH METASTATIC CASTRATION-SENSITIVE PROSTATE CANCER RECEIVING APALUTAMIDE PLUS ANDROGEN DEPRIVATION THERAPY (TITAN STUDY)

Overview

cited authors

Batten, Julia; Chi, Kim N.; Given, Robert; Karsh, Lawrence; Bhaumik, Amitabha; Agarwal, Neeraj

authors

Karsh, Lawrence, MD, FACS, CPI

Publication Date

March 1, 2024

webpage

Web of Science

published in

ONCOLOGY NURSING FORUM Journal

301 E Princeton St., Orlando, FL 32804 | FH.RAS@AdventHealth.com | 407-200-2901

The information on this website is not a substitute for examination, diagnosis, and medical care provided by a licensed and qualified health professional. Please consult your physician before undertaking any form of medical treatment and/or adopting any exercise program or dietary guidelines. If you think you may have a medical emergency, call your physician or 911 immediately. AdventHealth Research Institute reserves the right to add, remove or edit content on this page at its sole discretion.